iRhythm Holdings Inc (IRTC)

NASD · Healthcare · Medical Devices · USA

iRhythm Holdings Inc is a mid cap company (market value between $2 billion and $10 billion) in the Medical Devices industry.

iRhythm Holdings creates portable cardiac monitoring devices and associated software to assist physicians in diagnosing heart rhythm disorders. The company operates diagnostic testing facilities offering continuous monitoring services through patch-based sensors worn for extended periods. Its services help identify arrhythmias in patients who may have infrequent or subtle heart rhythm abnormalities.

From its FY2025 annual report (Form 10-K)

Intrinsic value, DCF valuation, financial health and value investing analysis for the iRhythm Holdings Inc stock.

Our verdict on IRTC

Overvalued: intrinsic value $66.73 per share, market price $89.67, margin of safety -34.4% (as of 2026-11-17).

A 2.8x revenue multiple, discounted for its losses, values the shares at $66.73; the price of $89.67 is 34% above that value.

ETFs with the most weight in IRTC

17 more funds hold it; the full list is part of the paid plan.

More on IRTC

Browse

Peers in Medical Devices

All 140 Medical Devices stocks

Cheaper than IRTC in Medical Devices

25 more in this industry show a wider margin of safety.

Is IRTC undervalued or overvalued?

IRTC is overvalued (as of the 2026-11-17 close). A 2.8x revenue multiple, discounted for its losses, values the shares at $66.73; the price of $89.67 is 34% above that value.

What is the intrinsic value of IRTC?

$66.73 per share (as of the 2026-11-17 close), against a market price of $89.67. That is a margin of safety of -34.4%. The value comes from the one valuation method that applies to this company, recomputed every night after the US close.